This site is intended for Healthcare Professionals only.

GPhC urge healthcare professionals to meet regulatory standard amid national shortage of Type 2 diabetes medicines

Date:

Share post:

The General Pharmaceutical Council (GPhC) has urged health and care professionals to meet relevant regulatory standards amidst the shortage of GLP-1 receptor agonists (GLP-1 RAs).

The council said: “We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs). We know that these are being widely prescribed for weight loss purposes and in some cases prescribed off-label.”

“We recognise the adverse impact that shortages and supply chain issues can have on patients, the public and wider health and care teams.

The Council understands that health and care professionals are using their professional judgement and making decisions in challenging situations, balancing a range of factors such as individual patient needs, wider public health and pressures and limitations on available resources such as medicines shortages or other supply chain issues.

However, it has urged health and care professionals to meet relevant regulatory standards in these circumstances, and they should be able to account for their decisions. This includes acting professionally at all times and providing person-centred care, using their knowledge and experience to make evidence-based decisions.

It added: “It’s vital that health and care professionals advise on, prescribe, supply, dispense or administer medicines within the limits of their training, competence and scope of practice, regulatory standards and guidance and the law. Alongside profession-specific codes of conduct, standards and guidance, health and care professionals are also expected to take account of relevant national policy and guidance.

“In this context, health and care professionals, including prescribers, are expected to take account of the RPS ‘Competency Framework for all Prescribers’ and apply this to reflect different areas of practice or situations. The framework sets out what good prescribing looks like and outlines key competencies such as the identification of evidence-based treatment options available for clinical decision making and prescribing (including prescribing medicines that are unlicensed, off-label, or outside standard practice).

The framework highlights the need for prescribers to assess the risks and benefits to the patient of taking or not taking a medicine or treatment, and to consider the wider perspective including the public health issues related to medicines and their use and promoting health.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

Knights Pharmacy expands footprint in South Wales with acquisition of 2 new pharmacies

Knights pharmacy to provide independent prescribing services at the new locations in South Wales Knights Pharmacy has significantly expanded...

Pharmacy bodies respond to Labour Party manifesto promises on community pharmacy

Pharmacy leaders have urged funding boost for pharmacies in response to Labour's ambitious healthcare plans The Labour Party's election...

RPS calls on political leaders to end prescription charges for long-term conditions

RPS and PCC urge political leaders to urgently get rid of prescription charges for chronic conditions on the...

Corsodyl unveils new toothpaste and mouthwash range targeted at preventing gum problems

New Corsodyl Gum Strength & Protect line includes clinically proven formulas to enhance gum health and prevent issues With...